May 17, 2020

Epic's New Edge? An App Store Just for Health Care Professionals

mHealth
EHR
mHealth
EHR
Admin
2 min
Epic is a privately held health care software company, whose systems are installed in large major hospitals, and hold the medical records of 54% of patients in the U.S. and 2.5% of patients worldwide.
Epic Systems – the health IT giant based in Verona, Wisconsin – is planning to launch its own app store called the “App Exchange.&rdqu...

Epic Systems – the health IT giant based in Verona, Wisconsin – is planning to launch its own app store called the “App Exchange.”

Similar to Apple’s iTunes store, the exchange would allow developers to create apps that integrate with Epic’s EHR platform.

The news, first reported by the Wisconsin State Journal, was announced by Mark Bakken, co-founder and former chief executive of Nordic Consulting, the largest consulting firm working with customers of Epic.

[READ MORE] Why Every Health Care Professional Needs businessfriend on Their Phone

Bakken said the app store will launch in the coming weeks and could serve as a economic boom for companies to develop and market their apps, especially those in the Madison area populated by former Epic employees.

“We think Apple is big now? This will cement their long-term legacy. It’s exactly the right thing to do,” said Bakken in an interview with the newspaper.

Similar to Apple, Epic will soon publish a set of application standards and guidelines for app developers. Bakken stated that the first set of apps will be focused on Epic’s customers followed by consumer-focused apps.

[READ MORE] 4 Reasons Telemedicine Will Trend Upward in 2015

“It will really open the floodgates for anyone that knows Epic to really get their product on the market quickly and in front of Epic’s customers. So the distribution channel will be huge,” Bakken noted.  

According to the journal, Bakken said the App Exchange should squash some of the criticism Epic has drawn from those who say its system is too closed.

Additionally, interoperability could prove crucial as the U.S. Department of Defense (DoD) considers which team should receive a contract worth up to $11 billion over five years to install an EHR system for the U.S. military. Epic and IBM have submitted a joint application for that contract, which is expected to be awarded later this year.

Follow us on Twitter (@HealthcareGlbl) and like us on Facebook!

Share article

Jun 23, 2021

Introducing Dosis - the AI powered dosing platform

AI
medication
personalisedmedicine
chronicdisease
3 min
Dosis is an AI-powered personalised medication dosing platform that's on a mission to transform chronic disease management

Cloud-based platform Dosis uses AI to help patients and clinicians tailor their medication plans. Shivrat Chhabra, CEO and co-founder, tells us how it works. 

When and why was Dosis founded?
Divya, my co-founder and I founded Dosis in 2017 with the purpose of creating a personalised dosing platform. We see personalisation in so many aspects of our lives, but not in the amount of medication we receive. We came across some research at the University of Louisville that personalised the dosing of a class of drugs called ESAs that are used to treat chronic anaemia. We thought, if commercialised, this could greatly benefit the healthcare industry by introducing precision medicine to drug dosing. 

The research also showed that by taking this personalised approach, less drugs were needed to achieve the same or better outcomes. That meant that patients were exposed to less medication, so there was a lower likelihood of side effects. It also meant that the cost of care was reduced. 

What is the Strategic Anemia Advisor? 
Dosis’s flagship product, Strategic Anemia Advisor (SAA), personalises the dosing of Erythropoiesis Stimulating Agents (ESAs). ESAs are a class of drugs used to treat chronic anaemia, a common complication of chronic kidney disease. 

SAA takes into account a patient’s previous ESA doses and lab levels, determines the patient’s unique response to the drug and outputs an ESA dose recommendation to keep the patient within a specified therapeutic target range. Healthcare providers use SAA as a clinical decision support tool. 

What else is Dosis working on? 
In the near term, we are working on releasing a personalised dosing module for IV iron, another drug that’s used in tandem with ESAs to treat chronic anaemia. We’re also working on personalising the dosing for the three drugs used to treat Mineral Bone Disorder. We’re very excited to expand our platform to these new drugs. 

What are Dosis' strategic goals for the next 2-3 years? 
We strongly believe that personalised dosing will be the standard of care within the next decade, and we’re honored to be a part of making that future a reality. In the next few years, we see Dosis entering partnerships with other companies that operate within value-based care environments, where tools like ours that help reduce cost while maintaining or improving outcomes are extremely useful.

What do you think AI's greatest benefits to healthcare are?
If designed well, AI in healthcare allows for a practical and usable way to deploy solutions that would not be feasible otherwise. For example, it’s possible for someone to manually solve the mathematical equations necessary to personalise drug dosing, but it is just not practical. AI in healthcare offers an exciting path forward for implementing solutions that for so long have appeared impractical or impossible.

Share article